New cancer drug kills breast cancer, leukemia cells.
NEW CANCER DRUG KILLS BREAST CANCER CELLS
Our developmental-stage cancer drug is essentially free from serious side effects. It’s a breakthrough because it selectively kills cancer cells over normal, healthy cells and is well tolerated by humans. Physicians and patients will prefer it to current, debilitating chemotherapies.
ARMACEUTICA IS SPONSORING A CLINICAL TRIAL
Our study is evaluating the safety and efficacy of pyronaridine as an add-on therapy in adults with acute lymphoblastic leukemia and acute myeloid leukemia. Our study is in countries where pyronaridine is an approved drug for malaria. The primary objective of our study is a comparison of survival lengths between the subjects receiving pyronaridine and placebo.
